{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:42:22Z","timestamp":1787002942728,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41391-017-0028-3","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T14:40:01Z","timestamp":1514904001000},"page":"168-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"21","author":[{"given":"Mohannad A.","family":"Awad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Gaither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Charles","family":"Osterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin N.","family":"Breyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"28_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u2013E86.","journal-title":"Int J Cancer"},{"key":"28_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1200\/JCO.2009.26.0133","volume":"28","author":"MR Cooperberg","year":"2010","unstructured":"Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28:1117\u201323.","journal-title":"J Clin Oncol"},{"key":"28_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.urpr.2015.01.001","volume":"2","author":"RH Blackwell","year":"2015","unstructured":"Blackwell RH, Kandabarow AM, Gupta GN, Harkenrider MM, Quek ML, Flanigan RC. Long-term incidence of hematuria, urethral stricture and bladder cancer after radiation therapy for prostate cancer. Urol Pract. 2015;2:349\u201358.","journal-title":"Urol Pract"},{"key":"28_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0167-8140(96)01880-4","volume":"42","author":"MK Tibbs","year":"1997","unstructured":"Tibbs MK. Wound healing following radiation therapy: a review. Radiother Oncol. 1997;42:99\u2013106.","journal-title":"Radiother Oncol"},{"key":"28_CR5","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.juro.2013.10.147","volume":"191","author":"MD Hofer","year":"2014","unstructured":"Hofer MD, Zhao LC, Morey AF, Scott JF, Chang AJ, Brandes SB, et al. Outcomes after urethroplasty for radiotherapy induced bulbomembranous urethral stricture disease. J Urol. 2014;191:1307\u201312.","journal-title":"J Urol"},{"key":"28_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"28_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ijrobp.2005.07.981","volume":"64","author":"RG Stock","year":"2006","unstructured":"Stock RG, Stone NN, Cesaretti JA, Rosenstein BS. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys. 2006;64:527\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"28_CR8","unstructured":"Wells G, Shea B, O\u2019connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011."},{"key":"28_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jclinepi.2014.03.003","volume":"67","author":"JP Hunter","year":"2014","unstructured":"Hunter JP, Saratzis A, Sutton AJ, Boucher RH, Sayers RD, Bown MJ. In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias. J Clin Epidemiol. 2014;67:897\u2013903.","journal-title":"J Clin Epidemiol"},{"key":"28_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.juro.2007.03.126","volume":"178","author":"SP Elliott","year":"2007","unstructured":"Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR, et al. Incidence of urethral stricture after primary treatment for prostate cancer: data from CaPSURE. J Urol. 2007;178:529\u201334.","journal-title":"J Urol"},{"key":"28_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.eururo.2014.08.061","volume":"67","author":"SL Jarosek","year":"2015","unstructured":"Jarosek SL, Virnig BA, Chu H, Elliott SP. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Eur Urol. 2015;67:273\u201380.","journal-title":"Eur Urol"},{"key":"28_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","volume":"98","author":"S Rodda","year":"2017","unstructured":"Rodda S, Tyldesley S, Morris WJ, Keyes M, Halperin R, Pai H, et al. ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high-and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2017;98:286\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"28_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijrobp.2010.10.009","volume":"82","author":"N Mohammed","year":"2012","unstructured":"Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, et al. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82:204\u201312.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"28_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.radonc.2012.06.001","volume":"104","author":"JJ Earley","year":"2012","unstructured":"Earley JJ, Abdelbaky AM, Cunningham MJ, Chadwick E, Langley SE, Laing RW. Correlation between prostate brachytherapy-related urethral stricture and peri-apical urethral dosimetry: A matched case\u2013control study. Radiother Oncol. 2012;104:187\u201391.","journal-title":"Radiother Oncol"},{"key":"28_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2007.11.004","volume":"86","author":"Y Seppenwoolde","year":"2008","unstructured":"Seppenwoolde Y, Kolkman-Deurloo I-K, Sipkema D, de Langen M, Praag J, Jansen P, et al. HDR prostate monotherapy\u2013dosimetric effects of implant deformation due to posture change between TRUS-and CT-imaging. Radiother Oncol. 2008;86:114\u20139.","journal-title":"Radiother Oncol"},{"key":"28_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.clon.2004.12.005","volume":"17","author":"G Morton","year":"2005","unstructured":"Morton G. The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol. 2005;17:219\u201327.","journal-title":"Clin Oncol"},{"key":"28_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.brachy.2011.07.006","volume":"11","author":"MA Myers","year":"2012","unstructured":"Myers MA, Hagan MP, Todor D, Gilbert L, Mukhopadhyay N, Randolf J, et al. Phase I\/II trial of single-fraction high-dose-rate brachytherapy\u2013boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate. Brachytherapy. 2012;11:292\u20138.","journal-title":"Brachytherapy"},{"key":"28_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brachy.2016.09.006","volume":"16","author":"DE Spratt","year":"2017","unstructured":"Spratt DE, Soni PD, McLaughlin PW, Merrick GS, Stock RG, Blasko JC, et al. American Brachytherapy Society Task Group Report: combination of brachytherapy and external beam radiation for high-risk prostate cancer. Brachytherapy. 2017;16:1\u201312.","journal-title":"Brachytherapy"},{"key":"28_CR19","doi-asserted-by":"crossref","unstructured":"Sweeney C, Xie W, Regan MM, Nakabayashi M, Buyse ME, Clarke NW, et al. Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP). American Society of Clinical Oncology; 2016;5023.","DOI":"10.1200\/JCO.2016.34.15_suppl.5023"},{"key":"28_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ijrobp.2004.12.068","volume":"62","author":"ZA Allen","year":"2005","unstructured":"Allen ZA, Merrick GS, Butler WM, Wallner KE, Kurko B, Anderson RL, et al. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity. Int J Radiat Oncol Biol Phys. 2005;62:981\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"28_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0360-3016(02)04600-X","volume":"56","author":"GS Merrick","year":"2003","unstructured":"Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH. Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2003;56:454\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"28_CR22","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0360-3016(00)01380-8","volume":"48","author":"WM Butler","year":"2000","unstructured":"Butler WM, Merrick GS, Dorsey AT, Hagedorn BM. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000;48:1575\u201382.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"28_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","volume":"91","author":"L Sullivan","year":"2009","unstructured":"Sullivan L, Williams SG, Tai KH, Foroudi F, Cleeve L, Duchesne GM. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol. 2009;91:232\u20136.","journal-title":"Radiother Oncol"},{"key":"28_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.brachy.2015.04.004","volume":"14","author":"A Bece","year":"2015","unstructured":"Bece A, Patanjali N, Jackson M, Whitaker M, Hruby G. High-dose-rate brachytherapy boost for prostate cancer: outcomes and genitourinary toxicity. Brachytherapy. 2015;14:670\u20136.","journal-title":"Brachytherapy"},{"key":"28_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijrobp.2010.09.021","volume":"82","author":"T Kaprealian","year":"2012","unstructured":"Kaprealian T, Weinberg V, Speight JL, Gottschalk AR, Roach M, Shinohara K, et al. High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes. Int J Radiat Oncol Biol Phys. 2012;82:222\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"28_CR26","volume-title":"Campbell\u2019s urology","year":"1998","unstructured":"Walsh PC, RA, Vaughan ED, Wein AJ, eds.. Campbell\u2019s urology. 7th ed. Philadelphia: WB Saunders; 1998.","edition":"7th ed"},{"key":"28_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1046\/j.1464-410x.1999.00908.x","volume":"83","author":"S Madersbacher","year":"1999","unstructured":"Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified. BJU Int. 1999;83:227\u201337.","journal-title":"BJU Int"},{"key":"28_CR28","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/0360-3016(86)90283-X","volume":"12","author":"CH Seymore","year":"1986","unstructured":"Seymore CH, El-Mahdi AM, Schellhammer PF. The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int J Radiat Oncol Biol Phys. 1986;12:1597\u2013600.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"28_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/jrr\/rrt128","volume":"55","author":"H Ishiyama","year":"2013","unstructured":"Ishiyama H, Satoh T, Kitano M, Tabata K-I, Komori S, Ikeda M, et al. High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up. J Radiat Res. 2013;55:509\u201317.","journal-title":"J Radiat Res"},{"key":"28_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0360-3016(01)01811-9","volume":"52","author":"GS Merrick","year":"2002","unstructured":"Merrick GS, Butler WM, Tollenaar BG, Galbreath RW, Lief JH. The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys. 2002;52:461\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41391-017-0028-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-017-0028-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-017-0028-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:33:01Z","timestamp":1684603981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-017-0028-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1038\/s41391-017-0028-3","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,2]]},"assertion":[{"value":"18 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}